https://kuraoncology.com/wp-content/uploads/AML_WorldAwarenessDay.jpg447800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-06-27 15:00:562024-06-28 10:33:04AML World Awareness Day 2024
https://kuraoncology.com/wp-content/uploads/MovingForwad_GivngBack.jpg450800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-06-27 13:00:032024-06-28 10:28:21Moving Forward, Giving Back: The ROI of Social Impact
https://kuraoncology.com/wp-content/uploads/Inflation_Thumbnail.jpg449800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-06-27 12:00:342024-08-15 11:31:24Kura CEO Troy Wilson on the Inflation Reduction Act
https://kuraoncology.com/wp-content/uploads/OncLive.png304557eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-03-21 18:38:282024-03-21 19:49:24Ziftomenib Combos Show Early Safety, Activity in NPM1-Mutant and KMT2A-Rearranged AML
https://kuraoncology.com/wp-content/uploads/Precision_Medicine_Online.png304557eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-03-21 18:20:582024-11-06 12:12:16Kura Oncology Reports Preliminary Data From Menin Inhibitor, Chemo Combination Trial in AML
https://kuraoncology.com/wp-content/uploads/fierce_bio.png304557eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-03-21 11:43:012024-03-22 15:20:19Kura’s Leukemia Treatment Performs Best When Tacked Onto Existing Combo, New Data Show
https://kuraoncology.com/wp-content/uploads/SC2402_Scrip-Asks-24-Part-5_1888758571_1200.jpg444790eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-02-15 13:38:472024-02-15 13:39:44Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends
https://kuraoncology.com/wp-content/uploads/PV-Outlook.png8521524eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2024-01-09 10:44:432024-01-09 11:08:08PharmaVoice’s Crystal Ball: Perspectives on the financial future